<b>Killing of human beta cells by CD8</b><sup><strong>+</strong></sup><b> T-cells triggers inflammatory paracrine signaling and neighboring beta cell dysfunction</b>
posted on 2025-11-12, 01:56authored byMasaya OSHIMA, Clémentine HALLIEZ, Farah KOBAISI, Nina MODE, Alexis FOUQUE, Barbara BRANDAO, Océane MAYER, Diego BALBOA, Roberto MALLONE, Raphael SCHARFMANN
<p dir="ltr">Type 1 diabetes is a progressive autoimmune disease characterized by the selective destruction of insulin-producing beta cells by CD8<sup>+</sup> T-cells. Although the mechanisms of antigen-specific beta cell killing are well established, the broader consequences of this targeted destruction on neighboring beta cells that escape direct TCR-mediated attack, remain poorly understood. Here, we developed a co-culture model of HLA-A2-expressing human beta cells cultured as pseudo-islets and CD8<sup>+</sup> T-cells specific for the INS<sub>15-24</sub> epitope. Using this new <i>in vitro</i> model, we demonstrate that (i) beta cell death induced by CD8<sup>+</sup> T-cells strictly depends on TCR-HLA class I interactions; (ii) neighboring beta cells that evade direct T-cell contact do not alter beta cell identity or glucose-stimulated insulin secretion. However, they exhibit increased expression of inflammatory markers, reduced insulin content and impaired protein translation. The robust, versatile and readily applicable model described here represents a strong basis to further address paracrine signaling that extend beyond direct cytotoxicity.</p>
Funding
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement no. 874839 (RS), Agence Nationale de la Recherche (ANR-22-CE14-0052-01) (RS), the Laboratoire d’Excellence consortium Revive (Investissements d'Avenir ANR-10-LABX-73-01) (RS), the Dutch Diabetes Research Foundation, the DON Foundation and the Innovative Medicines Initiative 2 Joint Undertaking under grant agreements 115797 945268 (INNODIA HARVEST), which receive support from the EU Horizon 2020 program, JDRF, and The Leona M. & Harry B. Helmsley Charitable Trust (RM and RS).